SPECTRUM HEALTH ZEELAND
1. Target Overview & Investment Thesis
SPECTRUM HEALTH ZEELAND is a 55-bed suburban community hospital in OTTAWA, MI with $100.0M in net patient revenue and a 17.9% operating margin. The hospital serves a payer mix of 14.8% Medicare, 3.1% Medicaid, and 82.2% commercial.
Thesis: Turnaround. Our ML models identify $7.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.9% to 25.3% (+736bps).
| Net Revenue HCRIS | $100.0M |
| Current EBITDA COMPUTED | $17.9M |
| Operating Margin COMPUTED | 17.9% |
| Occupancy HCRIS | 42.8% |
| Revenue / Bed COMPUTED | $1.8M |
| Net-to-Gross HCRIS | 37.0% |
| Distress Probability ML | 48.7% |
2. Market Context & Competitive Position
MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of 17.9% places it above the state median. Among 51 size-comparable peers (28-110 beds), the median margin is -5.9%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (28-110), prioritizing same-state peers. 51 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SPECTRUM HEALTH ZEELAND (Target) | MI | 55 | $100.0M | 17.9% |
| KARMANOS CANCER HOSPITAL | MI | 106 | $284.8M | -27.8% |
| MCLAREN OAKLAND | MI | 107 | $214.4M | 1.6% |
| TRINITY HEALTH LIVINGSTON | MI | 42 | $200.4M | 15.2% |
| CHELSEA HOSPITAL | MI | 79 | $187.8M | -1.1% |
| BEAUMONT HOSPITAL - TAYLOR | MI | 99 | $184.3M | -0.2% |
| BEAUMONT HEALTH WAYNE | MI | 97 | $180.7M | -3.6% |
| OAKLAWN HOSPITAL | MI | 78 | $156.6M | -12.4% |
| MYMICHIGAN MEDICAL CENTER ALMA | MI | 49 | $142.2M | -5.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $64K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $17.9M |
| + RCM Uplift | +$7.4M |
| Pro Forma EBITDA | $25.3M |
| Current Margin | 17.9% |
| Pro Forma Margin | 25.3% |
| WC Released (1x) | $3.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $27.6M | $191.9M | 6.95x | 47.4% |
| Base (11x exit) | 10.0x | 11.0x | $27.6M | $220.1M | 7.97x | 51.5% |
| Bull Case | 9.0x | 11.0x | $24.8M | $253.3M | 10.20x | 59.1% |
| Bull (12x exit) | 9.0x | 12.0x | $24.8M | $283.7M | 11.42x | 62.8% |
| Bear Case | 11.0x | 10.0x | $30.4M | $146.2M | 4.81x | 36.9% |
| Bear (11x exit) | 11.0x | 11.0x | $30.4M | $170.6M | 5.62x | 41.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 51 hospitals with 28-110 beds
- Same-state prioritization (n=52)
- Comp margins: P25=-13.8% / P50=-5.9% / P75=3.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.